Empowering Brands Through Tailored Clinical Pathways Solutions
Clinical Pathways have become a crucial tool for providers and payers to standardize evidence-based care and manage costs. Being off or disadvantaged on pathways can limit brand perception, uptake, and utilization. With decades of experience in the pathways space, The Dedham Group offers comprehensive pathways support tailored to product needs at different stages of lifecycle in oncology and other therapeutic areas.
Partner with us to elevate your brand positioning.
Partner with us
Our Tailored Services for Targeting Success:
1. Earlier Pipeline
- Evidence Requirement:
Gain insights into the pathways development process, evaluation criteria, and evidence requirements to secure favorable positioning within priority indications. - Data Generation & Submission Strategy:
Identify key endpoints and evidence sources (e.g., clinical trials, RWE) while adhering to best practices for data submission to enhance positioning post-approval.
2. Pre-Launch
- Pathways Landscape Assessment:
Gain a comprehensive understanding of pathways trends, adoption, implementation, development, product positioning, and key stakeholders related to priority indications - TPP Testing & Threats / Opportunities:
Identify anticipated threats and opportunities through TPP testing, historical analogs, etc., to inform engagement priorities.
- Customized Workshop / Training:
Develop and execute training sessions tailored to the audience (commercial vs. medical; HQ vs. field) to enhance internal buy-in and proficiency around pathways. - Engagement Model & Operational Planning:
Design a customized pathways engagement model, ensuring matrix team alignment, defining roles and responsibilities, and streamlining communication flow.
3. Post-Launch
- Pathways Dynamics Monitoring:
Regularly monitor changes in pathways and provide monthly/quarterly updates to guide evolving priorities. - PULSE Pathways Web Tool:
Utilize an interactive web tool with up-to-date pathways information and a monthly newsletter to support internal education and engagement planning. - Business Impact Evaluation:
Leverage data analytics to assess the impact of pathways management on business volume and market share over time. - Engagement Benchmarking & Model Optimization:
Identify internal gaps, best practices, and opportunities to optimize pathways engagement. - Competitive Scenario Planning:
Assess risks and opportunities upon competitive entrance and develop a defense strategy for optimizing pathways access.
We Provide:
In-depth Pathways Experience
Over 10 years of dedicated pathways experience, with a track record of 200+ pathways-related engagements in the past 5 years.
PULSE Analytics Web Tool
Leverage our proprietary in-house knowledge through PULSE Analytics, an up-to-date web-based tool offering robust databases and a monthly newsletter, ensuring you stay ahead in the dynamic pathways landscape.
Comprehensive Pathways Solutions
From pathways landscape assessment and internal training to data analytics, strategy development, operational planning, and ongoing tracking, The Dedham Group provides end-to-end solutions
Additional Resources
Reality Check on Urothelial/Bladder Cancer
A review of market access for treatments of urothelial/bladder cancer shows that most of the products currently approved are primarily processed through the medical benefit.
Urology Practices’ Growing Role in Oncology: Three Trends to Watch
The urology practice channel is one that pharma urologic oncology brands can’t afford to ignore without missing out on valuable business opportunities.
The Dedham Group is the leading U.S. market access consultancy that offers research, data analytics, & strategic consulting services to the life science industry.
2024 The Dedham Group | info@dedhamgroup.com